Clinical trial Recruiting at 1 site Interventional Ages 3 to 16

Transcutaneous spinal cord stimulation for children with incomplete spinal cord injury

Official title: Transcutaneous Spinal Cord Stimulation in Children With Incomplete Spinal Cord Injury: Safety, Feasibility, and Efficacy.

Run by Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · NCT06242873 · Data updated 2026-11-12

This study is testing if a new type of spinal cord stimulation can help children aged 3 to 16 with incomplete spinal cord injuries improve their walking while they receive special training.

Quick facts

Study typeInterventional
Ages3 Years to 16 Years
SexAll
Enrollment20 (estimated)
SponsorHugo W. Moser Research Institute at Kennedy Krieger, Inc.
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedMarch 3, 2022
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedMarch 2, 2026
Trial IDNCT06242873 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 3-16 who are at least six months post-injury and have a non-progressive spinal cord injury classified as AIS C or D.

Probably not a fit

Patients with progressive spinal cord injuries or those with active wounds may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the safety and feasibility of transcutaneous spinal cord stimulation (TSCS) in children aged 3 to 16 with incomplete spinal cord injuries. Participants will be randomly assigned to receive either TSCS or sham stimulation while undergoing eight weeks of individualized gait training. The primary outcomes will focus on measuring adverse events and compliance with the intervention protocol. Additionally, the study will assess the neurophysiologic impact of TSCS during a single session.

Why it matters

Potential benefit: If successful, this approach could enhance gait training outcomes and improve mobility for children with incomplete spinal cord injuries.

How similar studies have gone: While the specific application of TSCS in children is novel, similar approaches in adults have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 3-16
* ≥ 6 months post injury
* Non-progressive SCI
* American Spinal Injury Association Impairment Scale (AIS) Classification C or D AIS C is an incomplete classification where more than half of the key muscles below the neurological level have a muscle grade of 3 or less AIS D is an incomplete classification where more than half of the key muscles below the neurological level have a muscle grade of more than 3
* Neurologic level above T10
* Tolerates upright position for \>30 minutes
* Able to advance one lower extremity (LE) when in standing, bracing and assistive device allowed
* Medically stable (no hospitalizations in last 3 mos.)
* Able to comply with The International Standards for neurological and functional Classification of Spinal Cord Injury (ISNCSCI) exam

Exclusion Criteria:

* Progressive Spinal Cord Injury or Disease (SCI/D) (Multiple Sclerosis, Acute Disseminated Encephalomyelitis, etc.)
* Active wounds
* Range of motion limits impacting gait training
* Cardiac pacemaker/defibrillator
* Active cancer diagnosis
* Absent LE reflexes
* Pregnancy

Where it's running

  • Kennedy Krieger Institute
    Baltimore, Maryland, United States
    Recruiting

Study contacts

  • Principal investigator: Rebecca Martin, OTR/L, OTD, CPAM — Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
  • Study coordinator: Shannon M Inches
  • Email: inches@kennedykrieger.org
  • Phone: 443-923-9235

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.